C. Gay, J.D. Kuruc, S.D. Falcinelli, J. Warren, J.L. Kirchherr, K. Sholtis, . . . D.M. Margolis. (2019). The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 Infection. Elsevier.
Chicago Style (17th ed.) CitationC. Gay, et al. The Impact of Vorinostat and AGS-004, a Dendritic Cell-based Immunotherapy, on Persistent HIV-1 Infection. Elsevier, 2019.
MLA (9th ed.) CitationC. Gay, et al. The Impact of Vorinostat and AGS-004, a Dendritic Cell-based Immunotherapy, on Persistent HIV-1 Infection. Elsevier, 2019.
Warning: These citations may not always be 100% accurate.